The Microlyte Matrix is a synthetic skin substitute that is also antimicrobial as an alternative to allografts (e.g., Amnion) due to general safety concerns regarding donor tissue and xenografts (e.g., PuraPlyAM porcine small intestine submucosa) due to donor-site rejection of grafts with animal bi-products (see below image).  Other benefits include:

• Non-Toxic antimicrobial benefit, 99.99% effective (1ppm silver nanoparticles)

• Can be used at the onset of wound treatment or in surgery

• Contours to the micro-texture of the wound bed; assists with granulation process

• Cytophilic, bioresorbable scaffold for healthy cells to grow on

• Ready-to-use off the shelf with a 4-year shelf-life

• 510K cleared synthetic graft indicated for acute (e.g. surgical) chronic (DFU, VLU, PU), and burn (1st and 2nd degree) wounds; NOTE: VAMCs do not require tissue track core/log documentation since it is NOT allograft tissue

Website